Tue, January 20, 2009
Mon, January 19, 2009
Fri, January 16, 2009
Thu, January 15, 2009
Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update

Biodel Inc. to Present at 27th Annual JPMorgan Healthcare Conference on January 15th, 2009


//health-fitness.news-articles.net/content/2009/ .. -healthcare-conference-on-january-15th-2009.html
Published in Health and Fitness on Friday, January 9th 2009 at 13:53 GMT, Last Modified on 2009-01-09 13:53:20 by Market Wire   Print publication without navigation


DANBURY, Conn.--([ BUSINESS WIRE ])--Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solomon Steiner, Chairman and CEO of Biodel, will present a corporate update at the 27th Annual JPMorgan Healthcare Conference on Thursday, January 15, 2009 at 8:30 a.m. Pacific Time.

The JPMorgan Healthcare Conference will be held January 12-15, 2009, at the Westin St. Francis Hotel in San Francisco, California.

Interested parties may access the presentation in the investor relations section of Biodel's website at [ www.biodel.com ] which will link to a live webcast to be archived for 14 days.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed using VIAdelTM technology, which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at [ www.Biodel.com ].

BIOD-G


Publication Contributing Sources